FDA TPLC (Total Product Life Cycle): CDRH Guide

Q: What is FDA TPLC?

FDA TPLC (Total Product Life Cycle) is both the organizational model used by the FDA Center for Devices and Radiological Health (CDRH) to oversee medical devices across their entire lifespan and a public CDRH database. The TPLC database combines premarket clearance and approval data (510(k), PMA, De Novo, HDE) with postmarket adverse event reports (MAUDE) and recall records into a single report organized by 3-letter FDA product code.

Short answer: In U.S. medical device regulation, TPLC (Total Product Life Cycle) refers both to the organizational regulatory model of the FDA Center for Devices and Radiological Health (CDRH) and to the public CDRH Total Product Life Cycle (TPLC) Database. As a regulatory structure, CDRH’s Office of Product Evaluation and Quality (OPEQ) organizes review divisions into Offices of Health Technology (OHTs) that oversee a device type continuously from premarket bench and clinical evaluation through manufacturing quality, postmarket adverse event reporting, and recalls. As an informatics tool, the FDA TPLC database aggregates premarket submissions (510(k), PMA, De Novo, and HDE) alongside postmarket surveillance streams—Manufacturer and User Facility Device Experience (MAUDE) medical device reports and enforcement recalls—into a single statistical profile indexed by the FDA’s 3-letter product code.

What is FDA TPLC? Regulatory philosophy vs. CDRH database

Medical device researchers, regulatory affairs professionals, and clinical engineers encounter the acronym TPLC in two closely connected FDA contexts:

The CDRH TPLC Regulatory Approach (OPEQ and OHTs): Historically, CDRH separated premarket device review (the former Office of Device Evaluation) from postmarket surveillance and enforcement (the former Office of Surveillance and Biometrics and Office of Compliance). To eliminate information silos between premarket reviewers and postmarket safety analysts, CDRH consolidated these functions into the Office of Product Evaluation and Quality (OPEQ). Within OPEQ, specialty-focused Offices of Health Technology (OHT 1 through OHT 8) manage the complete lifecycle of specific device portfolios—meaning the same organizational unit reviews premarket submissions, evaluates Quality Management System (21 CFR Part 820) compliance, monitors postmarket safety signals, and coordinates recalls.
The Public CDRH TPLC Database: Maintained on the FDA’s AccessData portal, the TPLC database is a public query engine that generates a unified report for any generic category of medical device. Instead of querying separate silos for FDA 510(k) data, Premarket Approvals (PMAs), adverse events, and recalls, an investigator searches by a 3-letter FDA product code (procode) or generic device name to view premarket clearance volumes and postmarket failure modes side by side.

What data sources are integrated into an FDA TPLC product code report?

Every medical device regulated by CDRH or the Center for Biologics Evaluation and Research (CBER) is assigned a 3-letter product code linked to a classification regulation under 21 CFR Parts 862–892. When a user opens a product code report in the TPLC database, the FDA system compiles data from four primary regulatory repositories:

Device Classification & Regulatory Scope: Displays the 3-letter product code, preferred generic device name, medical specialty review panel, regulatory class (Class I, Class II, or Class III), 21 CFR citation, and whether the device is exempt from premarket notification.
Premarket Submissions (510(k), PMA, De Novo, and HDE): Summarizes historical clearance and approval activity for that product code, with direct links to cleared 510(k) premarket notifications, original PMA approvals and supplements, De Novo classification orders, and Humanitarian Device Exemptions (HDE).
Postmarket Adverse Event Reports (MAUDE / MDR under 21 CFR Part 803): Aggregates mandatory and voluntary Medical Device Reports (MDRs) submitted by manufacturers, importers, user facilities, and clinicians. The TPLC report breaks down total MDR counts by event type—malfunctions, injuries, and deaths—and lists the top reported device problem codes and patient problem codes across multi-year trends.
Medical Device Recalls (21 CFR Part 806 and Part 7): Lists Class I, Class II, and Class III medical device recalls associated with the product code, including recall numbers, recalling manufacturers, date initiated, and root-cause categories (such as software design, component failure, or labeling errors).

TPLC database vs. individual FDA databases and openFDA

When designing a regulatory landscape assessment, predicate device search, or postmarket safety study, researchers choose between the macro-level TPLC report and granular transactional databases:

Dimension	CDRH TPLC Database	Individual Databases (MAUDE, 510(k), Recalls) & openFDA
Unit of aggregation	3-letter FDA Product Code (generic device category)	Individual submission number (`K######`, `P######`), recall event ID, or MDR report number
Level of detail	Macro statistical summaries (annual counts of clearances, malfunctions, injuries, deaths, and top problem codes)	Micro-level records (narrative event descriptions, specific brand/model names, applicant addresses, and summary PDFs)
Primary research use case	Evaluating baseline risk profiles for a device class, identifying common failure modes before bench testing, and screening candidate predicate categories	Extracting full-text adverse event narratives, inspecting specific 510(k) substantial equivalence summaries, or running programmatic API queries
Update cadence	Refreshed periodically from underlying CDRH premarket and postmarket tables	Updated weekly or monthly per individual endpoint schedule

How TPLC informs Software as a Medical Device (SaMD) and AI/ML oversight

Beyond traditional hardware devices, the FDA applies its Total Product Life Cycle framework to Software as a Medical Device (SaMD) and artificial intelligence/machine learning (AI/ML)-enabled devices. Because adaptive and iterative software algorithms evolve faster than static hardware, CDRH’s AI/ML Action Plan and Predetermined Change Control Plan (PCCP) guidance rely on a TPLC model: manufacturers specify planned model retraining protocols, performance boundaries, and real-world performance monitoring commitments during the initial premarket submission, enabling postmarket algorithm updates within the cleared PCCP bounds without requiring a new 510(k) for every bounded modification.

How regulatory and clinical researchers use TPLC data in practice

Use-Related Risk Analysis (URRA) and ISO 14971 Hazard Identification: During premarket design controls (21 CFR § 820.30) and human factors engineering, regulatory teams query the TPLC report for their target product code to identify every known device problem code and patient harm logged across all competing devices in that category.
Predicate Selection and Special Controls Benchmarking: Before submitting a 510(k) or Pre-Submission (Q-Sub), sponsors inspect the TPLC profile to see clearance volume trends and whether recent recalls in that product code have prompted heightened CDRH scrutiny on specific bench or software validation tests.
Postmarket Epidemiological Research: Health services researchers combine TPLC product-code denominators (number of cleared devices and active manufacturers) with openFDA device adverse event endpoints to analyze postmarket safety trends across device classes.

Frequently asked questions

What is FDA TPLC?

FDA TPLC (Total Product Life Cycle) is both the organizational model used by the FDA Center for Devices and Radiological Health (CDRH) to oversee medical devices across their entire lifespan and a public CDRH database. The TPLC database combines premarket clearance and approval data (510(k), PMA, De Novo, HDE) with postmarket adverse event reports (MAUDE) and recall records into a single report organized by 3-letter FDA product code.

How do you find a device’s TPLC report on the FDA website?

You can look up a TPLC report on the FDA CDRH AccessData portal by entering either the device’s 3-letter Product Code (such as QAS or LLZ) or keywords from the generic device classification name. Every cleared 510(k) or approved PMA listing also includes a direct hyperlink from its product code field to the corresponding TPLC summary page.

Why can counts in a TPLC report differ slightly from a live MAUDE or Recall search?

The TPLC database compiles pre-aggregated statistical summaries keyed by the product code recorded on the submission or MDR form. If an individual adverse event report lacked a valid product code at initial intake or was filed after the most recent TPLC snapshot refresh, live queries directly against the MAUDE or Recall databases may return slightly different record counts.

FDA Total Product Life Cycle (TPLC): CDRH Database, Product Codes, Premarket Clearances, and Postmarket Surveillance